Skip to main content
. 2009 Mar;4(3):630–637. doi: 10.2215/CJN.03580708

Figure 2.

Figure 2.

Mean monthly percentage change in Epoetin alfa (EPO) dose during the sub-11 period (months 4 to 6) by the mean per administration EPO dose (units) in month 3 (last month of the entry period) and the mean achieved hemoglobin (Hb) level (g/dl) during the entry period (months 1 to 3).